Topical Sirolimus in Chemoprevention of Facial Squamous Cell Carcinomas in Solid Organ Transplant Recipients (SiroSkin)
Topical Sirolimus in Chemoprevention of Facial Squamous Cell Carcinomas in Solid Organ Transplant Recipients (SiroSkin)
Active, not recruiting · NCT05860881 · Registry updated 2025-09-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Topical Sirolimus in Chemoprevention of Facial Squamous Cell Carcinomas in Solid Organ Transplant Recipients (SiroSkin) | Neoplasms by Site, Skin and Connective Tissue Diseases, neoplasm, skin disorder, skin neoplasm | Active, not recruiting | Phase 3 | 2025-09-09 | NCT05860881 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Melanoma and Skin Cancer Trials Limited | 10 |
| Monash University | 75 |
| The University of Queensland | 41 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Princess Alexandra Hospital | Woolloongabba | Australia | 106 |
| Royal Prince Alfred Hospital | Camperdown | Australia | 83 |
| Skin Health Institute | Carlton | Australia | 3 |
| The Alfred Hospital | Melbourne | Australia | 110 |
| The Prince Charles Hospital | Chermside | Australia | 27 |
| Westmead Hospital | Westmead | Australia | 128 |